AbbVie (NYSE:ABBV) Stock Rating Upgraded by Barclays
Barclays upgraded shares of AbbVie (NYSE:ABBV – Free Report) from an equal weight rating to an overweight rating in a research note published on Monday morning, Marketbeat Ratings reports. The firm currently has $170.00 price objective on the stock, up from their prior price objective of $160.00. Several other equities research analysts also recently weighed […]
More Stories
First Farmers Financial (OTCMKTS:FFMR) Shares Up 0.5% – Here’s Why
First Farmers Financial Co. (OTCMKTS:FFMR – Get Free Report) shares traded up 0.5% on Thursday . The stock traded as...
QMX Gold (CVE:QMX) Stock Price Up 1.8% – Still a Buy?
QMX Gold Co. (CVE:QMX – Get Free Report) shares traded up 1.8% on Thursday . The company traded as high...
Hikma Pharmaceuticals (OTCMKTS:HKMPY) Trading Up 1% – Should You Buy?
Hikma Pharmaceuticals PLC (OTCMKTS:HKMPY – Get Free Report) shot up 1% during mid-day trading on Thursday . The stock traded...
Golden Tag Resources (CVE:GOG) Trading 10% Higher – Time to Buy?
Golden Tag Resources Ltd. (CVE:GOG – Get Free Report)’s share price traded up 10% on Thursday . The company traded...
Ceapro (CVE:CZO) Trading Down 11.8% – What’s Next?
Ceapro Inc. (CVE:CZO – Get Free Report) fell 11.8% during trading on Thursday . The company traded as low as...
Safehold (NYSE:SAFE) Sets New 52-Week Low Following Analyst Downgrade
Safehold Inc. (NYSE:SAFE – Get Free Report)’s stock price hit a new 52-week low during trading on Wednesday after The...